Schedule 13G ownership disclosure

Aura Biosciences Inc

Security class unavailable · CUSIP: 05153U107

Event date: 2021-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,023,857
Percent of class
6.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001062993-22-003816
Form type
SC 13G
Filer
Advent Life Sciences LLP
CIK
CIK 1601364
Filed
Feb 14, 2022
Reporting period
Dec 31, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub